Novel second generation analogs of eribulin. Part III: Blood–brain barrier permeability and in vivo activity in a brain tumor model
Keywords: مقاومت چند دارویی; UFNVPOGXISZXJD-JBQZKEIOSA-N; JBFLNPIQVUSWKG-ZRAYEYSSSA-NAntitumor agents; Microtubule; Multi-drug resistance; P-Glycoprotein; Glioblastoma; Blood–brain barrier permeability; Orthotopic brain tumor models